August 18, 2022 12:15 PM EDT
Pharma
FDA+
Manufacturing

Cipla man­u­fac­tur­ing site in In­dia lands a Form 483 for un­clean equip­ment, lack of da­ta

Tyler Patchen

News Reporter

While sev­er­al ma­jor In­di­an phar­ma­ceu­ti­cal man­u­fac­tur­ers have been cit­ed by the FDA this year, it ap­pears that Cipla is the lat­est to re­ceive a Form …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times